Skip to main content
Top
Published in: Diabetologia 3/2016

Open Access 01-03-2016 | Article

Random plasma glucose in early pregnancy is a better predictor of gestational diabetes diagnosis than maternal obesity

Authors: Claire L. Meek, Helen R. Murphy, David Simmons

Published in: Diabetologia | Issue 3/2016

Login to get access

Abstract

Aims/hypothesis

Asymptomatic pregnant women are screened for gestational diabetes (GDM) at 24–28 weeks’ gestation. Recent guidelines also recommend screening early in gestation to identify undiagnosed pre-existing overt diabetes. We assessed the performance of random plasma glucose (RPG) testing at antenatal booking in predicting GDM diagnosis later in pregnancy.

Methods

Data from 25,543 consecutive singleton pregnancies at the Rosie Hospital in Cambridge (UK) were obtained from hospital electronic records as a service evaluation. All women were invited for an antenatal RPG (12–16 weeks) and a 50 g glucose challenge test (GCT; 24–28 weeks) with a 75 g OGTT if GCT >7.7 mmol/l (139 mg/dl).

Results

At booking, 17,736 women had an RPG that was able to predict GDM (receiver operating characteristic AUC 0.8) according to various diagnostic criteria in common use. A cut-off point of ≥7.5 mmol/l (135 mg/dl) gave a sensitivity of 0.70 and a specificity of 0.90 for GDM diagnosis. Theoretically, using this screening policy, 13.2% of women would have been categorised at high risk (26.3% had GDM) and 86.8% of women at low risk (1.7% had GDM). RPG performed better than maternal age (AUC 0.60) or BMI (AUC 0.65) at predicting GDM diagnosis.

Conclusions/interpretation

RPG at booking has reasonable performance as a screening test and is better than maternal age or BMI for identifying women at high risk of GDM. RPG cannot replace OGTT for diagnosis but it may be useful to exclude women who do not need further investigation for GDM and to identify women who could be prioritised for early diagnosis or lifestyle interventions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Metzger BE, Coustan DR (1998) Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl 2):B161–B167PubMed Metzger BE, Coustan DR (1998) Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl 2):B161–B167PubMed
2.
go back to reference Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Mølsted-Pedersen L, Damm P (2008) Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand 87:59–62CrossRefPubMed Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Mølsted-Pedersen L, Damm P (2008) Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand 87:59–62CrossRefPubMed
3.
go back to reference Metzger BE, Lowe LP, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002CrossRefPubMed Metzger BE, Lowe LP, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002CrossRefPubMed
4.
go back to reference Metzger BE, Gabbe SG, Persson B et al (2010) International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRefPubMed Metzger BE, Gabbe SG, Persson B et al (2010) International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRefPubMed
6.
go back to reference American Diabetes Association (2014) Standards of medical care in diabetes—2014. Diabetes Care 37(Suppl 1):S14–S80CrossRef American Diabetes Association (2014) Standards of medical care in diabetes—2014. Diabetes Care 37(Suppl 1):S14–S80CrossRef
7.
go back to reference Vandorsten JP, Dodson WC, Espeland MA et al (2013) NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements 29:1–31PubMed Vandorsten JP, Dodson WC, Espeland MA et al (2013) NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements 29:1–31PubMed
8.
go back to reference National Institute of Clinical Excellence (NICE) (2015) Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. National Institute of Clinical Excellence (NICE) guideline NG3. Available from www.nice.org.uk/guidance/ng3/, accessed 30 October 2015 National Institute of Clinical Excellence (NICE) (2015) Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. National Institute of Clinical Excellence (NICE) guideline NG3. Available from www.​nice.​org.​uk/​guidance/​ng3/​, accessed 30 October 2015
9.
go back to reference Cundy T, Ackermann E, Ryan EA (2014) Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear. BMJ 348:g1567CrossRefPubMed Cundy T, Ackermann E, Ryan EA (2014) Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear. BMJ 348:g1567CrossRefPubMed
11.
go back to reference Committee on Practice Bulletins (Obstetrics) (2013) Practice bulletin no. 137: gestational diabetes mellitus. Obstet Gynaecol 122:406–416CrossRef Committee on Practice Bulletins (Obstetrics) (2013) Practice bulletin no. 137: gestational diabetes mellitus. Obstet Gynaecol 122:406–416CrossRef
12.
go back to reference Dahanayaka NJ, Agampodi SB, Ranasinghe OR et al (2012) Inadequacy of the risk factor based approach to detect gestational diabetes mellitus. Ceylon Med J 57:5–9CrossRefPubMed Dahanayaka NJ, Agampodi SB, Ranasinghe OR et al (2012) Inadequacy of the risk factor based approach to detect gestational diabetes mellitus. Ceylon Med J 57:5–9CrossRefPubMed
13.
go back to reference Simmons D, Devers MC, Wolmarans L, Johnson E (2009) Difficulties in the use of risk factors to screen for gestational diabetes mellitus. Diabetes Care 32, e8CrossRefPubMed Simmons D, Devers MC, Wolmarans L, Johnson E (2009) Difficulties in the use of risk factors to screen for gestational diabetes mellitus. Diabetes Care 32, e8CrossRefPubMed
14.
go back to reference Göbl CS, Bozkurt L, Rivic P et al (2012) A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus. Diabetologia 55:3173–3181CrossRefPubMed Göbl CS, Bozkurt L, Rivic P et al (2012) A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus. Diabetologia 55:3173–3181CrossRefPubMed
15.
go back to reference Jowett NI, Samanta AK, Burden AC (1987) Screening for diabetes in pregnancy: is a random blood glucose enough? Diabet Med 4:160–163CrossRefPubMed Jowett NI, Samanta AK, Burden AC (1987) Screening for diabetes in pregnancy: is a random blood glucose enough? Diabet Med 4:160–163CrossRefPubMed
16.
go back to reference van Leeuwen M, Opmeer BC, Yilmaz Y, Limpens J, Serlie MJ, Mol BW (2011) Accuracy of the random glucose test as screening test for gestational diabetes mellitus: a systematic review. Eur J Obstet Gynecol Reprod Biol 154:130–135CrossRefPubMed van Leeuwen M, Opmeer BC, Yilmaz Y, Limpens J, Serlie MJ, Mol BW (2011) Accuracy of the random glucose test as screening test for gestational diabetes mellitus: a systematic review. Eur J Obstet Gynecol Reprod Biol 154:130–135CrossRefPubMed
17.
go back to reference Church D, Halsall D, Meek C, Parker RA, Murphy HR, Simmons D (2011) Random blood glucose measurement at antenatal booking to screen for overt diabetes in pregnancy: a retrospective study. Diabetes Care 34:2217–2219PubMedCentralCrossRefPubMed Church D, Halsall D, Meek C, Parker RA, Murphy HR, Simmons D (2011) Random blood glucose measurement at antenatal booking to screen for overt diabetes in pregnancy: a retrospective study. Diabetes Care 34:2217–2219PubMedCentralCrossRefPubMed
18.
go back to reference Meek CL, Lewis HB, Patient C, Murphy HR, Simmons D (2015) Diagnosis of gestational diabetes mellitus: falling through the net. Diabetologia 58:2003–2012PubMedCentralCrossRefPubMed Meek CL, Lewis HB, Patient C, Murphy HR, Simmons D (2015) Diagnosis of gestational diabetes mellitus: falling through the net. Diabetologia 58:2003–2012PubMedCentralCrossRefPubMed
19.
go back to reference Kupke IR, Kather B, Zeugner S (1981) On the composition of capillary and venous blood serum. Clin Chim Acta 112:177–185CrossRefPubMed Kupke IR, Kather B, Zeugner S (1981) On the composition of capillary and venous blood serum. Clin Chim Acta 112:177–185CrossRefPubMed
20.
go back to reference van Leeuwen M, Zweers EJ, Opmeer BC et al (2007) Comparison of accuracy measures of two screening tests for gestational diabetes mellitus. Diabetes Care 30:2779–2784CrossRefPubMed van Leeuwen M, Zweers EJ, Opmeer BC et al (2007) Comparison of accuracy measures of two screening tests for gestational diabetes mellitus. Diabetes Care 30:2779–2784CrossRefPubMed
21.
go back to reference Tam WH, Rogers MS, Yip SK, Lau TK, Leung TY (2000) Which screening test is the best for gestational impaired glucose tolerance and gestational diabetes mellitus? Diabetes Care 23:1432CrossRefPubMed Tam WH, Rogers MS, Yip SK, Lau TK, Leung TY (2000) Which screening test is the best for gestational impaired glucose tolerance and gestational diabetes mellitus? Diabetes Care 23:1432CrossRefPubMed
22.
go back to reference Maegawa Y, Sugiyama T, Kusaka H, Mitao M, Toyoda N (2003) Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy. Diabetes Res Clin Pract 62:47–53CrossRefPubMed Maegawa Y, Sugiyama T, Kusaka H, Mitao M, Toyoda N (2003) Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy. Diabetes Res Clin Pract 62:47–53CrossRefPubMed
23.
go back to reference Mathai M, Thomas TJ, Kuruvila S, Jairaj P (1994) Random plasma glucose and the glucose challenge test in pregnancy. Natl Med J India 7:160–162PubMed Mathai M, Thomas TJ, Kuruvila S, Jairaj P (1994) Random plasma glucose and the glucose challenge test in pregnancy. Natl Med J India 7:160–162PubMed
24.
go back to reference Nasrat AA, Johnstone FD, Hasan SA (1988) Is random plasma glucose an efficient screening test for abnormal glucose tolerance in pregnancy? Br J Obstet Gynaecol 95:855–860CrossRefPubMed Nasrat AA, Johnstone FD, Hasan SA (1988) Is random plasma glucose an efficient screening test for abnormal glucose tolerance in pregnancy? Br J Obstet Gynaecol 95:855–860CrossRefPubMed
25.
go back to reference Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R (2000) Gestational diabetes mellitus diagnosed during early pregnancy. Am J Obstet Gynecol 182:346–350CrossRefPubMed Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R (2000) Gestational diabetes mellitus diagnosed during early pregnancy. Am J Obstet Gynecol 182:346–350CrossRefPubMed
26.
go back to reference Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R (2003) Early diagnosis of gestational diabetes mellitus and prevention of diabetes-related complications. Eur J Obstet Gynecol Reprod Biol 109:41–44CrossRefPubMed Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R (2003) Early diagnosis of gestational diabetes mellitus and prevention of diabetes-related complications. Eur J Obstet Gynecol Reprod Biol 109:41–44CrossRefPubMed
27.
go back to reference Super DM, Edelberg SC, Philipson EH, Hertz RH, Kalhan SC (1991) Diagnosis of gestational diabetes in early pregnancy. Diabetes Care 14:288–294CrossRefPubMed Super DM, Edelberg SC, Philipson EH, Hertz RH, Kalhan SC (1991) Diagnosis of gestational diabetes in early pregnancy. Diabetes Care 14:288–294CrossRefPubMed
28.
go back to reference Zhu WW, Yang HX, Wei YM et al (2013) Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care 36:586–590PubMedCentralCrossRefPubMed Zhu WW, Yang HX, Wei YM et al (2013) Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care 36:586–590PubMedCentralCrossRefPubMed
29.
go back to reference van Leeuwen M, Louwerse MD, Opmeer BC et al (2012) Glucose challenge test for detecting gestational diabetes mellitus: a systematic review. BJOG 119:393–401CrossRefPubMed van Leeuwen M, Louwerse MD, Opmeer BC et al (2012) Glucose challenge test for detecting gestational diabetes mellitus: a systematic review. BJOG 119:393–401CrossRefPubMed
Metadata
Title
Random plasma glucose in early pregnancy is a better predictor of gestational diabetes diagnosis than maternal obesity
Authors
Claire L. Meek
Helen R. Murphy
David Simmons
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 3/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3811-5

Other articles of this Issue 3/2016

Diabetologia 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine